Related references
Note: Only part of the references are listed.Endothelial and fibroblastic activation in scleroderma: The myth of the “uninvolved skin”
Henry N. Claman et al.
ARTHRITIS AND RHEUMATISM (2010)
c-MET pathway involvement in chronic rhinosinusitis: A genetic association analysis
Roberto Castano et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2010)
Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7
Manasi N. Shukla et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
The antifibrogenic effect of hepatocyte growth factor (HGF) on renal tubular (HK-2) cells is dependent on cell growth
Ciro Esposito et al.
GROWTH FACTORS (2009)
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans - Possible role in systemic sclerosis
Galina S. Bogatkevich et al.
ARTHRITIS AND RHEUMATISM (2007)
Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts
Humphrey Gardner et al.
ARTHRITIS AND RHEUMATISM (2006)
Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma
Tsuyoshi Iwasaki et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis
CS Zurita-Salinas et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Systemic and cell type-specific gene expression patterns in scleroderma skin
ML Whitfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin
M Kubo et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3
WH Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds
MS Ågren et al.
EXPERIMENTAL DERMATOLOGY (2001)
European multicentre study to define disease activity criteria for systemic sclerosis.: II.: Identification of disease activity variables and development of preliminary activity indexes
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Share Paper
